Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
17.24
-0.98 (-5.38%)
At close: Jan 30, 2026, 4:00 PM EST
17.06
-0.18 (-1.04%)
After-hours: Jan 30, 2026, 7:59 PM EST
TNXP Market Cap
TNXP has a market cap or net worth of $213.63 million as of January 30, 2026. Its market cap has increased by 392.06% in one year.
Market Cap
213.63M
Enterprise Value
24.00M
1-Year Change
392.06%
Ranking
Category
Stock Price
$17.24
Market Cap Chart
Since July 16, 2019, TNXP's market cap has increased from $7.29M to $213.63M, an increase of 2,828.99%. That is a compound annual growth rate of 67.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 213.63M | 10.37% |
| Dec 31, 2025 | 193.56M | 214.02% |
| Dec 31, 2024 | 61.64M | 160.94% |
| Dec 29, 2023 | 23.62M | 5.35% |
| Dec 30, 2022 | 22.42M | -87.36% |
| Dec 31, 2021 | 177.42M | 37.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 227.67M |
| Achieve Life Sciences | 222.52M |
| Palisade Bio | 222.01M |
| Voyager Therapeutics | 216.84M |
| Climb Bio | 213.42M |
| Arcturus Therapeutics Holdings | 212.25M |
| SAB Biotherapeutics | 208.99M |
| Nuvectis Pharma | 207.74M |